NCT03801122View on ClinicalTrials.gov

Evolution of Thromboelastography During Tranexamic Acid Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

March 9, 2022

Study Completion Date

July 11, 2022

Conditions
Hematological Malignancies Treated With Intensive Chemotherapy
Interventions
DRUG

Tranexamic acid

Administration of tranexamic acid, with 3 injections/8 hours.

Trial Locations (1)

42055

CHU de Saint-Etienne, Saint-Etienne

All Listed Sponsors
collaborator

Institut de Cancérologie de la Loire

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT03801122 - Evolution of Thromboelastography During Tranexamic Acid Treatment | Biotech Hunter | Biotech Hunter